118 related articles for article (PubMed ID: 9210004)
21. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
[TBL] [Abstract][Full Text] [Related]
22. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
23. Clinical indications and efficacy of colloidal bismuth subcitrate.
Lambert JR
Scand J Gastroenterol Suppl; 1991; 185():13-21. PubMed ID: 1957121
[TBL] [Abstract][Full Text] [Related]
24. Roxithromycin in the eradication of Helicobacter pylori.
Goh KL; Chuah SY; Azian M; Parasakthi N; Peh SC; Wong NW; Lo YL; Ong KK
Am J Gastroenterol; 1994 Nov; 89(11):2099-100. PubMed ID: 7942758
[No Abstract] [Full Text] [Related]
25. The actions of bismuth in the treatment of Helicobacter pylori infection.
Lambert JR; Midolo P
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():27-33. PubMed ID: 9146788
[TBL] [Abstract][Full Text] [Related]
26. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
27. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
29. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.
de Boer WA; Driessen WM; Potters VP; Tytgat GN
Am J Gastroenterol; 1994 Nov; 89(11):1993-7. PubMed ID: 7942724
[TBL] [Abstract][Full Text] [Related]
30. Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori.
Neeman A; Kadish U
J Clin Gastroenterol; 1994 Jul; 19(1):17-9. PubMed ID: 7930425
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
Chung KH; Lee DH; Jin E; Cho Y; Seo JY; Kim N; Jeong SH; Kim JW; Hwang JH; Shin CM
Gut Liver; 2014 Nov; 8(6):605-11. PubMed ID: 25368747
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
[TBL] [Abstract][Full Text] [Related]
33. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Wang Z; Wu S
Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
[TBL] [Abstract][Full Text] [Related]
34. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
Chen TS; Tsay SH; Chang FY; Lee SD
Am J Gastroenterol; 1994 Sep; 89(9):1511-4. PubMed ID: 8079929
[TBL] [Abstract][Full Text] [Related]
35. Mono and dual therapy for Helicobacter pylori associated gastritis.
Gill HH; Desai HG; Mehta PR; Ranganathan S; Kalro RH; Murti PK; Prabhu SR
J Assoc Physicians India; 1991 Oct; 39(10):743-5. PubMed ID: 1816196
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
[TBL] [Abstract][Full Text] [Related]
37. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
38. Role of metronidazole resistance in therapy of Helicobacter pylori infections.
Rautelin H; Seppälä K; Renkonen OV; Vainio U; Kosunen TU
Antimicrob Agents Chemother; 1992 Jan; 36(1):163-6. PubMed ID: 1590683
[TBL] [Abstract][Full Text] [Related]
39. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication.
Xia W; Zhang X; Wang J; Sun C; Wu L
Br J Nutr; 2012 Jul; 108(2):357-62. PubMed ID: 22004585
[TBL] [Abstract][Full Text] [Related]
40. [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].
Calvet X; Gené E
Gastroenterol Hepatol; 2003 May; 26(5):325-9. PubMed ID: 12732108
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
